 LAKE FOREST, Ill., Feb. 11, 2021 PRNewswire -- Akorn Operating Company LLC Akorn, a leading specialty pharmaceutical company, announced that it received approval of its Abbreviated New Drug Application ANDA from the U.S. Food and Drug Administration FDA for Loteprednol Etabonate... 